Tofacitinib induces G1 cell-cycle arrest and inhibits tumor growth in Epstein-Barr virus-associated T and natural killer cell lymphoma cells. [electronic resource]
Producer: 20180226Description: 76793-76805 p. digitalISSN:- 1949-2553
- Animals
- Apoptosis -- drug effects
- Biomarkers
- Cell Line, Tumor
- Disease Models, Animal
- Epstein-Barr Virus Infections -- complications
- G1 Phase Cell Cycle Checkpoints -- drug effects
- Gene Expression Regulation, Viral -- drug effects
- Herpesvirus 4, Human -- genetics
- Humans
- Janus Kinase 3 -- metabolism
- Killer Cells, Natural -- drug effects
- Lymphocyte Activation -- drug effects
- Lymphoma, T-Cell -- etiology
- Mice
- Piperidines -- pharmacology
- Protein Kinase Inhibitors -- pharmacology
- Pyrimidines -- pharmacology
- Pyrroles -- pharmacology
- STAT5 Transcription Factor -- metabolism
- T-Lymphocytes -- drug effects
- Tumor Burden -- drug effects
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.